Status:
RECRUITING
Real-world Lithium Intake
Lead Sponsor:
University of Aarhus
Conditions:
Bipolar Disorder (BD)
Eligibility:
All Genders
18+ years
Brief Summary
The aim of the present study is to study compliance with lithium therapy and patterns of lithium intake among a representative group of patients with bipolar disorder in a real-world clinical setting....
Detailed Description
Bipolar disorder is a severe mental disorder1 and lithium represents the first-line pharmacological treatment1-5. The individual lithium dose is based on monitoring of clinical effect and lithium bloo...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Diagnosed with bipolar disorder (ICD-10: F30-31)
- Followed at the bipolar disorder outpatient clinic at AUHP
- Treated with lithium (ATC-code: N05AN01)
- Able to give informed oral and written consent.
Exclusion
- Any coercive measure in the study period including patients in forensic psychiatry.
- In a clinical condition where the treating clinician evaluates that the patient is not able to attend the research study.
Key Trial Info
Start Date :
July 5 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 15 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT07167563
Start Date
July 5 2025
End Date
July 15 2026
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinic for Bipolar Disorder, Aarhus University Hospital Psychiatry
Aarhus, Denmark